ISDA

Deposition Date 2013-12-10

Release Date 2014-08-27

Last Version Date 2024-02-28

Entry Detail

PDB ID:

4NY9

Keywords:

TRANSCRIPTION/TRANSCRIPTION inhibitor

Title:

Crystal Structure Of the Human PXR-LBD In Complex With N-{(2R)-1-[(4S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylpiperidin-1-yl]-3-methyl-1-oxobutan-2-yl}-3-hydroxy-3-methylbutanamide

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.80 Å

R-Value Free:

0.29

R-Value Work:

0.22

R-Value Observed:

0.23

Space Group:

P 43 21 2

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Nuclear receptor subfamily 1 group I member 2
Gene (Uniprot):NR1I2
Chain IDs:A
Chain Length:290
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:O75469 Pfam ID:PF00104

Ligand Molecules

2Q4

GOL

Primary Citation

Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis.

Santella, J.B, Gardner, D.S, Duncia, J.V, Wu, H, Dhar, M, Cavallaro, C, Tebben, A.J, Carter, P.H, Barrish, J.C, Yarde, M, Briceno, S.W, Cvijic, M.E, Grafstrom, R.R, Liu, R, Patel, S.R, Watson, A.J, Yang, G, Rose, A.V, Vickery, R.D, Caceres-Cortes, J, Caporuscio, C, Camac, D.M, Khan, J.A, An, Y, Foster, W.R, Davies, P, Hynes, J.Show

J.Med.Chem. 57 7550 7564 (2014)

PMID: 25101488 DOI: 10.1021/jm5003167

Abstact

High-affinity, functionally potent, urea-based antagonists of CCR1 have been discovered. Modulation of PXR transactivation has revealed the selective and orally bioavailable CCR1 antagonist BMS-817399 (29), which entered clinical trials for the treatment of rheumatoid arthritis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures